News & Media

2008
April 28, 2008		AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug, Boardroom Radio interview
April 28, 2008		Excellence in Biotechnology Investment Presentation, Boardroom Radio interview
April 24, 2008		Arana and Kyowa Hakko to Co-develop Anti-Cancer Drug
April 14, 2008		Corporate presentation - April 08
March 18, 2008		Sky TV: Update on Phase II Trial Status
March 18, 2008		ARANA THERAPEUTICS LIMITED (AAH) provides the opportunity to listen to an audio broadcast with Dr John Chiplin and Dr David Fuller, Managing Director / CEO and Chief Medical Officer in a presentation titled "AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer".
March 17, 2008		Arana Announces Start of Phase II Trial for Lead Compound
February 14, 2008		Arana AGM 2008
February 4, 2008		Sky TV: ART621 Phase II set to start
February 4, 2008		Arana achieves milestone in collaboration with CSL
February 1, 2008		Arana announces sale of animal health division
January 14, 2008		Arana Therapeutics Performance Share Plan
January 11, 2008		2008 shareholder notice of meeting for Arana Therapeutics Limited
January 9, 2008		Arana announces final receipt of $17.7 million from sale of Domantis Limited
2007
December 28, 2007		Arana announces resignation of director
December 17, 2007		Relocation of registered office
December 11, 2007		Arana announces resignation of director
December 6, 2007		IBC Conference Presentation
December 5, 2007		Sky TV: ART621 Phase II Trials Set to Start
December 4, 2007		Arana Announces Phase II trials for Lead Compound ART621	TOP
November 30, 2007		AAH - Arana Therapeutics Completes Project With CSL - Mr Rob Crombie, VP Business Development
November 29, 2007		Arana Therapeutics Completes Project With CSL
November 19, 2007		Bloomberg TV: Arana Name change and ART621 Phase II Trial Announcement
November 19, 2007		Change of Director's Interest Notice
November 12, 2007		Arana investor presentation
November 9, 2007		Arana Therapeutics Reports Strong Financial
November 9, 2007		2007 Annual Results
November 8, 2007		Arana launches new business strategy
November 1, 2007		Peptech announces board changes
October 29, 2007		Peptech successfully completes Phase I trial for PN0621
October 8, 2007		Notice of General Meeting
October 2, 2007		Peptech commercialisation agreement with AVEO
September 12, 2007		Peptech signs partner to distribute Suprelorin® in Europe
August 28, 2007		Peptech pays scheme consideration to evogenix shareholders
August 27, 2007		Peptech announces director retirements
August 17, 2007		Evogenix receives court order regarding merger with Peptech
August 16, 2007		EvoGenix to commence second project with GlaxoSmithKline
August 9, 2007		Shareholders Approve Peptech-Evogenix Merger
August 9, 2007		PTD Merger Announcement on ASX
July 13, 2007		Sky News Australia Sky Business Report
July 12, 2007		Peptech presentation to eG Capital Forum
July 11, 2007		Peptech presentation to eG Capital Forum
July 5, 2007		Change in Directors Interest Notice x 2
June 28, 2007		EvoGenix Scheme Booklet
June 26, 2007		Peptech to conduct global search for new Chairman
June 22, 2007		Peptech wins Best Newcomer award 2007 at the Annual London Stock Exchange MediScience Awards
June 20, 2007		Peptech Half Year Report
June 18, 2007		Peptech renegotiates Biosceptre joint venture	TOP
June 13, 2007		Peptech establishes International Scientific Advisory Board
June 6, 2007		PTD - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec. Director and Dr Cliff Holloway, VP of Bus. Development
June 6, 2007		Peptech appoints Chief Medical Officer
May 22, 2007		PTD Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director
May 22, 2007		Peptech enters Phase I clinical trial of PN0621
May 21, 2007		Peptech UK roadshow presentation
May 17, 2007		Record Profit for Half Year Boardroom Radio interview
May 17, 2007		Peptech announces record profit
May 17, 2007		Peptech 2007 Half Year Results
May 16, 2007		Chairmans letter to shareholders
May 8, 2007		Notice of initial substantial holder
May 7, 2007		Peptech and Evogenix merger Boardroom Radio interview
May 7, 2007		Peptech and Evogenix merger presentation
May 7, 2007		Peptech and Evogenix merge to form antibody powerhouse
May 3, 2007		Peptech’s Pipeline Boosted With A$6.6M Government Grant
May 1, 2007		Peptech presentation
April 30, 2007		Peptech to present at key international conferences
April 5, 2007		Peptech strengthens board with new appointment
March 21, 2007		Peptech Animal Health Boardroom radio interview
March 19, 2007		Suprelorin® recommendation clears path for sales in Europe
March 16, 2007		Corporate presentation
March 16, 2007		Peptech antibody technology platform breakthrough
March 14, 2007		Peptech appoints global financial adviser
February 8, 2007		Peptech AGM February 2007
February 8, 2007		Peptech to explore private equity options
January 31, 2007		Peptech launches next generation Suprelorin12
January 8, 2007		Peptech realises A$178m with Domantis sale completion	TOP